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Introduction
Cyclin-dependent kinases (Cdks) and their regulatory cyclin 
subunits play a crucial role in cell cycle control (Hunt and 
Murray, 1993). In budding and fi  ssion yeast, a single Cdk, bound 
to different sets of cyclins, initiates DNA synthesis and centro-
some duplication, suppresses re-replication of already dupli-
cated DNA, and triggers entry into mitosis once replication is 
complete (Nasmyth, 1993; Stern and Nurse, 1996). Higher 
  eukaryotes have evolved a group of specialized Cdks, each of 
which is active in a different phase of the cell cycle (Malumbres, 
2005). Cdk1 together with cyclin A and B forms the maturation-
promoting factor, and is required for entry into mitosis. Cdk2 
bound to cyclin E and A was considered to be essential for 
initiation and completion of DNA replication, and the control of 
centrosome duplication, until several groups found that mice 
lacking Cdk2 develop normally (Berthet et al., 2003; Ortega 
et al., 2003). This raises the question of which Cdk controls 
the initiation and completion of S phase in the absence of Cdk2. 
Although Cdk1 is an apparent candidate for this redundant S phase 
Cdk, as Aleem et al. (2005) proposed, an essential function for 
vertebrate Cdk1 during G1 and S phase has not been directly 
demonstrated. In fact, Cdk4 has also been implicated recently 
as a back up kinase for Cdk2 in G1 phase (Berthet et al., 2006). 
Hence, we do not know to what extent different Cdks overlap in 
the initiation of S phase in vertebrate cells.
In addition to the initiation of replication, the inhibition of 
endoreplication is another essential S phase function of yeast 
Cdk1, which ensures that each replication origin fi  res only 
once per cell cycle by inhibiting the untimely assembly of pre-
replication complexes (pre-RCs) (Diffl  ey, 2004). At the exit from 
mitosis, Cdk1 activity is shut down by the anaphase promoting 
complex, also known as cyclosome (APC/C), which triggers 
cyclin destruction (Zachariae et al., 1998). This inactivation of 
Cdk1 by cyclin proteolysis seems suffi  cient for the re-licensing 
of origins in the next G1 phase (Noton and Diffl  ey, 2000). This 
idea is supported by the observation that artifi  cial inactivation 
and reactivation of yeast Cdk1 are suffi  cient to reset the cell 
  cycle and induce endoreplication (Hayles et al., 1994). Several 
studies also implicate Cdk1 in the inhibition of endoreplication 
in fl  ies and human cells (Hayashi, 1996; Itzhaki et al., 1997; 
Coverley et al., 1998). However, higher eukaryotes, but not yeast, 
contain an additional licensing inhibitor, Geminin, which binds 
to and inactivates the pre-RC assembly factor Cdt1 (McGarry 
and Kirschner, 1998; Wohlschlegel et al., 2000; Tada et al., 2001). 
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n vertebrates Cdk1 is required to initiate mitosis; how-
ever, any functionality of this kinase during S phase 
  remains unclear. To investigate this, we generated chicken 
DT40 mutants, in which an analog-sensitive mutant cdk1
as replaces the endogenous Cdk1, allowing us to speciﬁ  -
cally inactivate Cdk1 using bulky ATP analogs. In cells that 
also lack Cdk2, we ﬁ  nd that Cdk1 activity is essential for 
DNA replication initiation and centrosome duplication. 
The presence of a single Cdk2 allele renders S phase pro-
gression independent of Cdk1, which suggests a complete 
overlap of these kinases in S phase control. Moreover, 
we ﬁ  nd that Cdk1 inhibition did not induce re-licensing 
of replication origins in G2 phase. Conversely, inhibition 
during mitosis of Cdk1 causes rapid activation of endo-
replication, depending on proteolysis of the licensing in-
hibitor Geminin. This study demonstrates essential functions 
of Cdk1 in the control of S phase, and exempliﬁ  es a 
chemical genetics approach to target cyclin-dependent 
  kinases in vertebrate cells.
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Moreover Cdk-dependent and -independent proteolysis path-
ways regulate the stability of the licensing factor, Cdt1 during 
S phase (Arias and Walter, 2007). It remains elusive how Geminin, 
Cdk1 activity, and proteolysis of Cdt1 are coordinated to sup-
press endoreplication in human cells.
The following two questions arise regarding the contribu-
tion of Cdk1 to the control of S phase: Is Cdk1 involved in the 
initiation of DNA replication and centrosome duplication? Is 
Cdk1 inhibition suffi  cient to induce endoreplication in verte-
brate cells, despite the presence of Geminin? These questions 
have not been suffi  ciently addressed, owing to the diffi  culty to 
specifi  cally, rapidly, and effectively inactivate Cdk1. In fact, 
a conditional deletion of the Cdk1 promotor in a human cell line 
has been achieved, but the levels of the kinase drop only very 
slowly and incompletely (Itzhaki et al., 1997). A mouse cell line 
(FT210) that carries a temperature-sensitive mutation has also 
been isolated, but this cell line appears to maintain about 25% 
kinase activity at the restrictive temperature (Th’ng et al., 1990). 
A variety of chemical inhibitors of Cdk1, such as Roscovitine 
and Olomoucine, have been used to explore Cdk1 function 
(Fischer et al., 2003; Vassilev et al., 2006). However, these 
inhibitors are likely to affect other kinases within and pos-
sibly outside of the Cdk family. To increase the specifi  city of 
chemical inhibition, Shokat and coworkers recently developed 
a chemical genetics approach to sensitize kinases to bulky ATP 
analogs by mutating a conserved bulky residue in the active site 
(Bishop et al., 2001; Shokat and Velleca, 2002). This strategy 
has been successfully applied to Cdk1 and other kinases in yeast 
(Bishop et al., 2000), and a similar approach has been exploited 
to study Jun and Trk kinase in mouse models (Chen et al., 2005; 
Jaeschke et al., 2006; Ventura et al., 2006) and in human cells to 
analyze Cdk7 (Larochelle et al., 2007).
We have taken advantage of the high gene-targeting fre-
quencies in chicken DT40 cells to disrupt the endogenous 
chicken CDC2 gene, encoding the Cdk1 kinase, and ectopi-
cally express a mutant Cdk1 cDNA (cdk1as) that is selectively 
sensitive to inhibition by the ATP analog 1NM-PP1. Using this 
system, we have investigated S phase functions of vertebrate 
Cdk1. We found that Cdk1 activity is essential for triggering 
DNA replication and centrosome duplication in cells lacking 
Cdk2. Conversely, if Cdk2 is present, Cdk1 inhibition does not 
delay S phase or block centrosome duplication. We also show 
that whereas inhibition of Cdk1 in G2 phase, before entry into 
mitosis, does not induce endoreplication, inhibition of Cdk1 
during prometaphase does stimulate origin licensing and endo-
replication. This depends on the proteo  lysis of Geminin. These 
results clarify the role of vertebrate Cdk1 in controlling repli-
cation and endoreplication.
Results
Selective inhibition of Cdk1 by chemical 
genetics results in a reversible G2 arrest
We initiated this study by establishing DT40 cell lines, in which 
we disrupted the endogenous chicken Cdk1 by gene targeting 
and exogenously expressed either an analog sensitive F80G mu-
tant (cdk1as) or wild-type (cdk1WT) cDNA of Xenopus laevis 
Cdk1 (Fig. S1, A–E; available at http://www.jcb.org/cgi/content/
full/jcb.200702034/DC1). We isolated two independent cdk1as 
cell lines, with slightly different levels of Cdk1as expression. 
The cdk1as1 cell line grew with similar kinetics as DT40 WT 
cells, whereas cdk1as2 cells that expressed less Cdk1 transgene 
showed a slight growth retardation. (Fig. S1 F). In both cases 
the activity of the Cdk1 kinase was reduced when compared 
with WT Cdk1, probably due to the F80G mutation in the active 
site. We continued to work with the cdk1as1 cell line, hereafter 
called cdk1as cells.
To confi  rm that the mutant Cdk1 was indeed selectively 
sensitive to the bulky ATP analog inhibitor 1NM-PP1, we 
immunoprecipitated Cdk1 from extracts of Cdk1-defi  cient cells 
reconstituted with WT Xenopus Cdk1 (cdk1WT cells) or cdk1as 
cells, and measured the Cdk1 kinase activity of the immuno-
precipitates in the presence or absence of 1NM-PP1, using 
Histone H1 as a substrate. Although the amount of Cdk1 was 
comparable in the immunoprecipitates (unpublished data), the 
kinase activity of cdk1as cells was reduced to about 20% of WT 
Xenopus Cdk1 activity (Fig. 1, A and B). Addition of 10 μM 
1NM-PP1 inhibited phosphorylation of Histone H1 by the mu-
tant kinase but had no effect on the WT Cdk1. Likewise, 10 μM 
1NM-PP1 had no effect on the growth of cdk1WT cells, but 
abolished proliferation of cdk1as cells (Fig. 1 C).
To investigate the effects of Cdk1 inhibition on the cell 
cycle, we isolated the G1 fraction of cdk1WT and cdk1as cells 
by elutriation, added 10 μM 1NM-PP1 to the media, and took 
samples every 2 h for FACS analysis of the DNA content. 
Fig. 1 D shows that both cell lines initiated and completed S phase 
with very similar kinetics. The cdk1WT cells subsequently com-
pleted mitosis and re-entered the next cell cycle, whereas cdk1as 
cells remained arrested in the 4N state (Fig. 1, D and E). This 
arrest was maintained for several days without further division 
and DNA synthesis (Fig. 1 E).
To analyze the activity of the APC/C in the arrested cells, 
we measured cyclin levels in arrested cdk1as cells, in which de 
novo protein synthesis was inhibited by cycloheximide (CHX). 
Both cyclins were stable during the G2 arrest for more than 6 h 
after CHX treatment (Fig. 1 F, left). CHX did not interfere with 
cyclin destruction after the release from a Nocodazole block, 
excluding the possibility that CHX itself affects the proteolysis 
of cyclins (Fig. 1 F, right). We also found that cyclin B2 local-
ized predominantly in the cytoplasm throughout this prolonged 
arrest (Fig. 1 G). These observations indicate that Cdk1 inhibi-
tion blocks the cell cycle in the G2 phase before APC/C activa-
tion and translocation of cyclin B to the nucleus.
To explore whether the arrest induced by Cdk1 inhibition 
was reversible, we removed 1NM-PP1 after 8 h incubation of 
cdk1as cells with the inhibitor. This resulted in rapid entry into 
M phase, as evidenced by Histone H3 phosphorylation, and 
cyclin destruction, during a synchronous passage through mito-
sis (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200702034/DC1). These fi  ndings suggest that the active 
state of Cdk1, including association of cyclin B, is unaltered 
during the 1NM-PP1 mediated inhibition of cdk1as, allowing 
the rapid activation of Cdk1 upon removal of the inhibitor dur-
ing the G2 arrest.CHEMICAL GENETIC ANALYSIS OF CDK1 IN DT40 CELLS • HOCHEGGER ET AL. 259
Cdk1 and Cdk2 have overlapping 
functions in both S phase progression 
and centrosome duplication
To explore the redundancy of Cdk1 and Cdk2 during S phase, 
we disrupted the chicken CDK2 gene to generate cdk1as/
cdk2
−/− mutants (Fig. S3, available at http://www.jcb.org/cgi/
content/full/jcb.200702034/DC1). Ablation of Cdk2 had little 
effect on DT40 WT cells, but retarded the cellular proliferation 
in the cdk1as background even in the absence of 1NM-PP1 
(Fig. 2, A and B). Accordingly, cdk1as/cdk2
−/− cells that were 
synchronized in G1 phase by elutriation took approximately 2 h 
longer than cdk1as cells to initiate S phase (compare the FACS 
histogram in Fig. 2 C with Fig. 1 D). Nonetheless, the double-
mutant cells were still able to complete S phase and accumu-
lated in G2 phase even in the presence of a low dose (1 μM) of 
1NM-PP1 (Fig. 2 D). A tenfold higher dose of the inhibitor 
blocked the asynchronous cell cycle both in G1 and G2, as 
judged by the histogram of DNA content (Fig. 2 D). This sug-
gests that Cdk1 is responsible for S phase control in the absence 
of Cdk2.
We next analyzed the centrosomes by γ-tubulin staining 
in arrested cdk1as and cdk1as/cdk2
−/− cells. 8 h after Cdk1 in-
hibition, cdk1as cells contained two separated centrosomes, and 
the centrosome number appeared to double subsequently during 
8-h intervals (Fig. 2, E and F). A similar separation and dou-
bling of the centrosomes occurred in cdk1as/cdk2
−/− cells that 
were treated with 1 μM 1NM-PP1 (Fig. 2 E). However, the cen-
trosomes no longer duplicated in cdk1as/cdk2
−/− treated with 
10 μM 1NM-PP1 (Fig. 2, E and F). This phenotypic difference 
between cdk1as and cdk1as/cdk2
−/− cells indicates that Cdk1 
Figure 1.  Inhibition of Cdk1 by chemical genetics in DT40 cells results in a G2 arrest. (A) Histone H1 kinase assays with 9E10 immunoprecipitates from 
CDC2 gene-disrupted DT40 cells, reconstituted with myc-tagged Xenopus cdk1WT or cdk1as cDNAs. Each immunoprecipitate was split and washed with 
buffer containing equal amounts of either DMSO or 10 μM 1NM-PP1. Samples from the kinase assay were taken at the indicated incubation times and 
analyzed by SDS-PAGE and autoradiography to detect 
32P-labeled Histone H1. For a comparison of Cdk1 levels in the immunoprecipitates, see Fig. S1 G. 
(B) Quantiﬁ  cation of the Histone H1 kinase activity of cdk1WT and cdk1as immunoprecipitates in the presence (+) or absence of (−) 10 μM 1NM-PP1. Shown 
are values relative to the activity of cdk1WT kinase, 16 min after initiation of the reaction. The mean values and SD of four independent experiments are 
shown. (C) Proliferation kinetics of Cdk1-deﬁ  cient DT40 cells reconstituted with either cdk1WT or cdk1as cDNAs in the presence (+) or absence (−) of 
10 μM 1NM-PP1. (D) Cell cycle proﬁ  le of cdk1WT and cdk1as cells. Cells were synchronized in G1 phase by elutriation at time zero and cultured for 10 h 
in medium containing 10 μM 1NM-PP1. Samples were taken every 2 h and analyzed by PI staining and FACS. (E) Cell cycle analysis of BrdU pulse-labeled 
cdk1as cells incubated with 10 μM 1NM-PP1 for 0, 12, 24, and 48 h. The X-axis of the dot blot shows the content of DNA on a linear scale; the Y-axis 
shows the BrdU uptake on a log scale. (F) Cyclin stability in 1NM-PP1 arrested cdk1as cells. The cells arrested in G2 phase by a 12-h incubation with 10 μM 
1NM-PP1. 100 μg/ml CHX were added and whole-cell extracts were analyzed by SDS-PAGE and immunoblotting at the indicated times. To rule out an 
  interference of CHX with proteolysis cdk1as cells were released from a 4-h Nocodazole arrest in the absence or presence of 100 μg/ml CHX. Cyclin B 
or Cdk1 amounts were measured by immunoblotting at the indicated times after the release. (G) Localization of cyclin B2 in the cytoplasm of cdk1as cells 
treated with 10 μM 1NM-PP1. Samples were taken at the indicated times, ﬁ  xed, and analyzed by immunoﬂ  uorescence (bar, 10 μm), using the anti–chicken 
B2 antibody (red color), and DAPI staining of DNA (blue color).JCB • VOLUME 178 • NUMBER 2 • 2007  260
and Cdk2 share overlapping functions in the control of both 
DNA replication and centrosome duplication.
Cdk1 activity is required to initiate but 
not to sustain DNA synthesis throughout 
S phase, in cells lacking Cdk2
We aimed to analyze the S phase functions of Cdk1 in cdk1as/
cdk2
−/− cells in closer detail, by examining cell cycle progression. 
We collected the G1 fraction of cells, treated them with 10 μM 
1NM-PP1, and analyzed the subsequent progression through 
the cell cycle (Fig. 3, A and B). The G1 fraction of cdk1as/cdk2
−/+ 
cells was able to increase their DNA content (Fig. 3 A), and up-
take BrdU (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200702034/DC1) in the presence of 1NM-PP1. In con-
trast, the same dose of the inhibitor completely abolished the 
cell cycle progression and BrdU uptake in cdkas/cdk2
−/− cells 
(Fig. 3 B; Fig. S4). These observations indicate functional redun-
dancy between Cdk1 and Cdk2 for the initiation of S phase.
To confi  rm this notion, we examined the cell cycle pro-
gression in asynchronous populations of cdk1as/cdk2
−/+ and 
cdk1as/cdk2
−/− cells using pulse-chase BrdU labeling. After 10 min 
of BrdU exposure, G1, S, and G2 fractions of the cells were 
clearly distinguishable by dot blot analysis of BrdU/PI double 
staining (Fig. 3 C). BrdU was subsequently removed from the 
medium and the cells were further incubated in the presence of 
10 μM 1NM-PP1. Both the G1 and S phase population of 
  cdk1as/cdk2
−/+ cells were able to complete DNA synthesis, and 
the entire population of the cells was blocked in the G2 phase. 
Conversely, the G1 fraction of the homozygous cdk1as/cdk2
−/− 
mutants did not initiate DNA synthesis, whereas the mid S phase 
cells were shifted toward G2 (Fig. 3 C). Thus, although ongoing 
DNA synthesis during S phase does not appear to require 
Cdk1/2 activity, either Cdk1 or Cdk2 activity is essential to 
initiate DNA replication.
To further explore this G1 arrest induced by Cdk1 inhibi-
tion in cdk1as/cdk2
−/− cells, we measured the levels of cyclin A 
and B in cells synchronized in G1 by elutriation (Fig. 3 D). Both 
cyclins accumulated even after addition of 10 μM 1NM-PP1, 
suggesting that Cdk1/2 inhibition does not interfere with the 
expressions of genes required for the G1/S transition.
Inhibition of Cdks in G2 phase does not 
result in endoreplication in DT40 or 
HeLa cells
Hayles et al. (1994) demonstrated that artifi  cial inactivation and 
reactivation of Schizosaccharomyces pombe Cdc2 in G2 phase 
is suffi  cient to reset the cell cycle and to initiate a further round 
of DNA replication, without previous chromosome segregation. 
To investigate whether a similar reversible inhibition of Cdk 
  activity is also suffi  cient to induce endoreplication in vertebrate 
cells, we synchronized cdk1as/cdk2
−/− cells in G2 phase by 
  addition of 1 μM 1NM-PP1 for 6 h, and subsequently increased 
the inhibitor concentration to 10 μM for an additional hour to 
completely block Cdk1 activity. Afterward, we washed the in-
hibitor out with excess medium, and monitored the cell cycle 
progression by measuring DNA content by using FACS analysis 
(Fig. 4 A). Surprisingly, unlike S. pombe, this inhibition and reactiv-
ation of Cdk1 in G2 phase did not result in endoreplication, 
and all cells initiated the next round of replication only after 
mitosis (Fig. 4 A; note the absence of cells containing DNA 
>4N). This observation is in marked contrast with a previous study 
by Itzhaki et al. (1997), who showed that a human fi  broblast 
Figure 2.  Effects of a Cdk2 deletion on cdk1as cells. (A) Growth curve of cdk1as/cdk2
−/− cells compared to the indicated controls. (B) Cell cycle distribu-
tion of the indicated cell lines, calculated from BrdU pulse labeling, phosphohistone H3 staining, and PI staining experiments. (C) Cell cycle analysis of 
  cdk1as/cdk2
−/− cells, following synchronization in G1 phase by elutriation. (D) Cell cycle analysis of cdk1as/cdk2
−/− and cdk1as/cdk2
−/+ cells treated 
for 8 h with the indicated concentration of 1NM-PP1. The control was not exposed to 1NM-PP1. (E) Centrosomes detected by γ-tubulin immunoﬂ  uorescence 
(green color) and counterstained with DAPI (blue color) in ﬁ  xed cdk1as and cdk1as/cdk2
−/− cells (bar, 10 μm), at the indicated times after 1 μM or 10 μM 
1NM-PP1 addition. (F) Average number of centrosomes per cell (n = 50) plotted against time after 10 μM 1NM-PP1 addition.CHEMICAL GENETIC ANALYSIS OF CDK1 IN DT40 CELLS • HOCHEGGER ET AL. 261
cell line continued to increase in ploidy, after conditional inhibi-
tion of Cdk1 expression.
To confi  rm that Cdk1 inactivation does not activate repli-
cation origins of cdk1as/cdk2
−/− cells, we analyzed the recruit-
ment of Mcm proteins, essential components of the pre-RC, to 
chromatin. In G2 phase, Mcm2–7 are excluded from chromatin, 
and need to be loaded as a hexameric ring structure onto the 
DNA to license origins for a new round of DNA replication. 
In correlation with the results in Fig. 4 A, we could not detect 
Mcm2, 3, and 4 in the chromatin fraction of cdk1as/cdk2
−/− 
cells that were synchronized in G2 by1 μM 1NM-PP1, and then 
further treated with 10 μM 1NM-PP1 to fully block Cdk1 (Fig. 
4 B, lane 5). Moreover, additional inhibition with the general 
Cdk inhibitor Roscovitine also failed to induce Mcm2–4 binding 
to chromatin (Fig. 4 B, lane 6). Thus, inhibition of both Cdk1 and 
Cdk2 during G2 phase may not be suffi  cient for origin licensing 
in chicken DT40 cells.
Previous studies suggested that the general kinase inhibitor 
DMAP induces Mcm loading onto chromatin in the G2 phase 
of HeLa cells (Coverley et al., 1996). We repeated the same 
experiments by inhibiting Cdks more specifi  cally by treating 
HeLa cells with Roscovitine. For this purpose, we synchro-
nized the cells in early S phase by a double thymidine block, 
released them, and analyzed the chromatin binding of both the 
licensing factor Cdt1 and Mcms, as cells progressed through 
S phase. After 7 h after release, when most cells were in G2 phase 
(Fig. 4 C), Mcms had been largely displaced from the chromatin 
(Fig. 4 D, lane 8). At this time, we added Roscovitine to the 
cells, while a control sample was left without Cdk inhibition 
(Fig. 4, C and D; compare “9” with “9+Ros”). Both samples 
were treated with Nocodazole, an inhibitor of spindle forma-
tion, to avoid the entry in the next G1 phase. In accordance with 
the results obtained with chemical genetics in DT40 cells (Fig. 4, 
A and B), Roscovitine did not appear to induce Mcm loading 
onto chromatin in the G2 population of HeLa cells (Fig. 4 D, 
lane 10). In conclusion, Cdk inhibition in G2 phase is not nec-
essarily suffi  cient to induce origin licensing in chicken and 
human cells.
Inhibition of Cdk1as in mitotic cells 
causes endoreplication
Vassilev et al. (2006) recently observed an induction of endo-
replication in Nocodazole arrested human cells treated with a 
Cdk1 inhibitor. We wished to know whether Cdk1 inhibition 
by the chemical genetics method also triggers endoreplication 
in mitotic DT40 cells. To avoid a prolonged treatment with 
  Nocodazole, we fi  rst synchronized cdk1as cells in G2 using 
1NM-PP1, and then released them into mitosis by removing the 
inhibitor, while adding Nocodazole to obtain cells that were 
briefl  y arrested in prometaphase (see diagram in Fig. 5 A). In 
contrast to the cells arrested in G2 (Fig. 4 C), the mitotic   cdk1as 
cells exhibited DNA replication without completing mitosis, 
  after addition of 10 μM 1NM-PP1 (Fig. 5 B). Cdk1 inhibition 
also led to rapid dephosphorylation of Histone H3, indicative of 
decondensation of chromosomes (Fig. 5 C). We also observed the 
quick dephosphorylation of the APC/C subunit Cdc27 (Fig. 5 D), 
which is hyperphosphorylated by Cdk1 in mitosis (Rudner 
and Murray, 2000). Moreover, we found that the APC/C was 
Figure 3.  Effects of Cdk1 inhibition on DNA repli-
cation and cyclin synthesis in cdk1as/cdk2
−/− and 
cdk1as/cdk2
−/+ cells. (A) Cdk1 inhibition does not 
prevent S phase in cdk1as/cdk2
−/+ cells. Cells 
synchronized in G1 by elutriation were incubated 
in 10 μM 1NM-PP1, and samples were taken 
  every 2 h for cell cycle analysis, as in Fig. 1 D. 
(B) Cdk1 inhibition in cdk1as/cdk2
−/− cells in-
hibits entry into S phase. The same experiment as 
in A was performed. (C) Inhibition of Cdk1 blocks 
the initiation of DNA synthesis in cdk1as/cdk2
−/− 
cells. Asynchronous cultures of cdk1as/Cdk2
−/+ 
or 
−/− cells were exposed to a 10-min pulse of 
BrdU and subjected to cell cycle analysis as in Fig. 
1 C (top panels). BrdU labeled cells were chased 
with BrdU-free medium containing 10 μM 1NM-
PP1 for a further 7 h (pulse-chase analysis shown in 
bottom panel). The X-axis of the dot blot shows the 
content of DNA on a linear scale; the Y axis shows 
the BrdU uptake on a log scale. Cells in the gate 
area represent the G1 fraction, of which the per-
centage is shown. (D) Time course of cyclin synthesis. 
Cells synchronized in G1 phase were incubated in 
the presence or absence of 10 μM 1NM-PP1. Cell 
extracts were analyzed by SDS-PAGE and immuno-
blotting at the indicated time points.JCB • VOLUME 178 • NUMBER 2 • 2007  262
activated in response to mitotic Cdk1 inhibition, as judged by 
the rapid degradation of cyclin A upon addition of the inhibitor 
(Fig. 5 E). Nocodazole arrested cdk1WT cells showed no such 
response to 1NM-PP1 and remained unchanged in mitosis 
(unpublished data). These data suggest that inhibition of endorepli-
cation may be carried out differently in G2 and M phase.
Endoreplication induced by Cdk1 inhibition 
in mitosis depends on proteolysis
A possible explanation for the differential effects of Cdk1 inhi-
bition on DNA synthesis in G2 and M phase could be the activa-
tion of APC/C mediated proteolysis during mitosis but not 
G2 phase (compare cyclin stability in Fig. 1 F and Fig. 5 E). To test 
this hypothesis, we treated cdk1as cells that were synchronized 
in mitosis as shown in Fig. 5 A with the proteasome inhibitor 
MG132 before Cdk1 inhibition. We found that MG132 pre-
vented the induction of DNA synthesis by 1NM-PP1 (compare 
Fig. 5 F with Fig. 5 B). Furthermore, MG132 suppressed the 
induction of Mcm loading on chromatin after Cdk1 inhibition 
(Fig. 5 G, compare lane 5 with lane 6). These results suggest 
that Cdk1 inhibition is not suffi  cient to allow origin licensing 
and endoreplication, unless proteolysis is activated.
Geminin needs to be degraded in human 
cells to allow origin licensing
To verify these results from DT40 cells in a human cell line, 
we analyzed Nocodazole-arrested HeLa cells treated with 
Roscovitine. We found that this Cdk inhibitor initiated origin 
  licensing, as judged by Cdt1 and Mcm2 loading onto chromatin, 
as previously described by Ballabeni et al. (2004). Inhibition of 
the proteasome by MG132 abolished the Roscovitine induced 
chromatin binding of Mcm2 and Cdt1 in HeLa cells (Fig. 6 A, 
lane 3 and lane 6), confi  rming our previous results with DT40 
cells (Fig. 5, F and G).
The proteolysis dependence of origin licensing and endo-
replication induced by Cdk1 inhibition, suggests that proteins other 
then cyclins need to be degraded to allow pre-RC formation. 
Geminin, which is an APC/C substrate and a licensing inhibitor 
(McGarry and Kirschner, 1998; Wohlschlegel et al., 2000), is a 
good candidate to account for this proteolysis requirement after 
Figure 4.  Analysis of DNA endoreplication and Mcm binding to chromatin after Cdk1 and Cdk1/2 inhibition in DT40 and HeLa cells. (A) Inhibition of 
Cdk1 does not trigger endoreplication in cdk1as/cdk2
−/− cells. The cells were treated with 1 μM 1NM-PP1 for 6 h to allow accumulation in G2 phase, 
followed by addition of 10 μM 1NM-PP1 for an additional hour (1–10 μM block). The inhibitor was washed out in excess medium and the cells 
were further incubated without the inhibitor for 14 h. At 2, 6, and 14 h after wash out, cell cycle analysis was performed. (B) Evaluation of origin 
licensing by analyzing chromatin binding of Mcm2-4 in cdk1as/cdk2
−/− cells. Asynchronous populations (lanes 1 and 4), and cells synchronized in 
G2 by a 12-h incubation in 1 μM 1NM-PP1, and then further treated with 10 μM 1NM-PP1 (lanes 2 and 5), or with 10 μM 1NM-PP1, and 50 μM 
Roscovitine (lanes 3 and 6) are shown. The indicated samples were subjected to chromatin fractionation and immunoblot analysis of the soluble (left) 
and chromatin (right) fraction. (C) Cell cycle analysis of HeLa cells released from a double thymidine block. At 7 h after release, 100 μM Roscovitine 
or DMSO was added to the cells, which were incubated for additional 2 h (9 and 9+Ros). Progression into the next G1 phase was inhibited by simul-
taneous addition of 100 ng/ml Nocodazole. (D) Lack of origin licensing in HeLa cells following Roscovitine treatment in G2. Cells were prepared as 
in C. Samples were analyzed by SDS-PAGE and immunoblotting with the indicated antibodies. Note the absence of Cdt1 and Mcms in the chromatin 
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Cdk inhibition. Accordingly, we found that Roscovitine trig-
gered the destruction of both cyclin B1 and Geminin (Fig. 6 A, 
lane 2), whereas MG132 treatment stabilized these proteins 
(Fig. 6 A, lane 3). Fig. 6 B shows that the APC/C targets Aurora 
kinase A and Cdc20 are also degraded upon Cdk inhibition dur-
ing mitosis.
To test if the inhibition of Geminin degradation is suffi  -
cient to prevent Roscovitine-induced origin licensing, we inves-
tigated the effects of ectopic expression of a Geminin mutant 
that is resistant to APC/C dependent degradation, on mitotic 
HeLa cells treated with Roscovitine (Benjamin et al., 2004). We 
transiently expressed this stable Geminin mutant in HeLa cells, 
after release from a double thymidine block. As a control ex-
periment, we expressed GFP or an APC/C-resistant mutant of 
mouse cyclin B1 in HeLa cells treated in the same manner. The 
transfected cells were arrested in prometaphase by Nocodazole 
treatment. In the control samples, licensing was initiated by the 
addition of Roscovitine, as judged by the chromatin loading of 
Mcms and Cdt1 (Fig. 6 C, lane 8 and lane 10). In contrast, ex-
pression of the stable Geminin mutant inhibited loading of Cdt1 
and Mcm onto chromatin in response to Roscovitine treatment 
(Fig. 6 C, lane 12). In fact, we observed that even overexpres-
sion of WT Geminin in mitosis partially inhibited Mcm loading 
(unpublished data). We conclude that Geminin needs to be 
targeted for degradation by the APC/C, even after Cdk inactiva-
tion, to allow for origin licensing and endoreplication in verte-
brate cells.
Geminin and proteolysis suppress 
endoreplication during G2 phase 
independently of Cdk activity
To clarify the relationship of Geminin and Cdks during G2 phase, 
we tested if Geminin depletion and Cdk inhibition is suffi  cient 
to induce origin licensing and endoreplication in HeLa cells, 
synchronized in G2 phase as shown in Fig. 7 B. Surprisingly, 
Roscovitine treatment during the G2 phase did not cause 
Mcm loading onto chromatin even after Geminin depletion 
(Fig. 7 A, lane 7). We noticed that in these cells Cdt1 was hardly 
detectable, suggesting the Cdk inhibition was not suffi  cient to 
stabilize this licensing factor during the G2 phase (note that the 
Cdt1 antibody used in this experiment and in bottom lane of 
Fig. 7 D, produces a cross-reacting band, marked with an asterisk). 
Conversely, inhibition of proteolysis by MG132 caused an in-
crease in Cdt1 levels, and resulted in origin licensing, however, 
only after Geminin depletion. This origin licensing in G2 oc-
curred with similar effi  ciency with or without Cdk inhibition 
(compare Fig. 7, lanes 11 and 12).
To test if these prematurely licensed origins were able to 
trigger re-replication we incubated cells synchronized in G2 with 
MG132 and/or Roscovitine. After 2 h we removed the inhibitors 
from the medium and measured the DNA content of the cells 
after further 12 h of incubation (see experimental outline in 
Fig. 7 B). The FACS histograms in Fig. 7 C show that Geminin 
depletion and MG132 treatment but not Cdk inhibition was suffi  -
cient to induce endoreplication in the majority of these G2 cells.
Figure 5.  Inhibition of Cdk1 in mitosis causes endoreplication depending on proteolysis. (A) Experimental design. After a 7-h exposure to 10 μM 1NM-PP1 
we released the cells from a G2 arrest into medium containing Nocodazole. After a 1-h incubation in Nocodazole, Cdk1 was again inhibited by the addi-
tion of 10 μM 1NM-PP1. (B) Endoreplication after inhibition of Cdk1 in mitosis. cdk1as cells arrested in prometaphase as described in A were incubated 
with 10 μM 1NM-PP1 and pulse labeled with BrdU at the indicated time points. Dot blot analysis is displayed as in Fig. 1 E. (C) Analysis of Histone H3 
phosphorylation in samples treated as described in A. Cells were ﬁ  xed at 10 min after the second Cdk1 inhibition or without inhibition, and stained with 
both PI (X-axis, linear scale) and anti phospho-Ser10 Histone H3 antibodies (Y-axis, log scale). (D) Analysis of Cdc27 phosphorylation by immunoblotting 
in cells synchronized in G2 phase or mitosis as described in A. 15 min after release from the 1NM-PP1 block into mitosis (lane M) Cdc27 shifts upwards 
due to hyper-phosphorylation by Cdk1. It remains phosphorylated after 1 h in Nocodazole (lane 1, Noc 1h). Following Cdk1 inhibition by addition of 
10 μM 1NM-PP1, Cdc27 is rapidly de-phosphorylated and shifts back to its G2 form within minutes (see lane 10’). (E) Immunoblot analysis of cyclin A and 
Histone H2A levels in Nocodazole arrested cdk1as cells at the indicated times after the second Cdk1 block. (F) Endoreplication initiated by the second 
Cdk1 inhibition is blocked by MG132. The same experiment as in B in the presence of the proteasome inhibitor MG132 is shown. (F) MG132 blocks origin 
licensing induced by the second Cdk1 inhibition. Chromatin fractionation of cdk1as cells arrested in mitosis as shown in A, before (lane 1 and 4) and 2 h 
after 1NM-PP1 addition (lane 2 and 5). To inhibit the proteasome, cells had been incubated for 1 h with MG132 before the 1NM-PP1 inhibitor was added 
(lane 3 and 6). Mcm and Histone H2A levels were measured by SDS PAGE and immunoblotting.JCB • VOLUME 178 • NUMBER 2 • 2007  264
Our results show that proteolysis has opposing effects on 
endoreplication during G2 and M phase. One of these differ-
ences could to be the stability of licensing factors such as Cdt1. 
We compared Cdt1 levels in G2 and M phase using two differ-
ent Cdt1 antibodies. For this purpose, we synchronized HeLa 
cells by a double thymidine release in G2 phase and inhibited 
cell cycle progression into M phase by Roscovitine addition, 
or allowed the cells to proceed into M phase by adding 
nocodazole. Fig. 7 D shows that Cdt1 levels decreased after Cdk 
inhibition by Roscovitine, but were markedly increased in the 
Nocodazole treated cells. These results indicate that Cdt1 levels 
are kept low during G2 phase independently of Cdk activity, 
and are rapidly increased after mitotic Cdk1 activation and entry 
into M phase.
Discussion
A chemical genetics approach to study 
Cdk1 in vertebrate cells
This study describes the use of chemical genetics to study verte-
brate Cdk1. We generated a chicken DT40 cell line, in which we 
compensated the deleted endogenous Cdk1 with a cdk1as mutant 
cDNA of the Xenopus laevis Cdk1 orthologue. The as-mutation 
of the active site has varying effects on different kinases. In the 
case of Cdk1, the mutation of F80G signifi  cantly reduces the 
activity of the kinase. To overcome this obstacle, we chose two 
different strategies. First, we used the Xenopus cDNA of Cdk1, 
because we found that this Cdk1 orthologue was relatively resistant 
to the introduction of the F80G mutation, retaining 20% of the 
WT kinase activity (see Fig. 1, A and B). Second, we aimed to 
compensate this fi  vefold reduction by overexpression of the mu-
tant kinase, and selected a stably transfected clone that showed 
a fourfold increase of Cdk1 levels when compared to Xenopus 
WAK cells (unpublished data). However, using a PSTAIRE 
  antibody that should cross-react to frog and chicken Cdk with 
the same affi  nity, we determined that the levels of the exoge-
nously expressed Cdk1 were approximately the same as the 
  endogenous chicken Cdk1 (Fig. S1 D). Our approach proved to 
be successful, and we were able to fully reconstitute the loss of 
the endogenous Cdk1 with the Xenopus cdk1as transgene.
Compared to conventional small molecule inhibitors, the 
advantage of this genetic approach lies primarily in its highly 
increased specifi  city, rapid action and reversibility (Shokat and 
Velleca, 2002). Accordingly, 1NM-PP1 had no discernable ef-
fect on cdk1WT cells. In cdk1as cells, on the other hand, the 
cellular Cdk1 activity was annulled within 10 minutes after in-
hibitor addition, as judged by dephosphorylation of Histone H3 
and the Cdk1 substrate Cdc27 (Fig. 5, C and D). This study 
shows that DT40 cells are a useful tool for chemical genetic 
analysis of vertebrate Cdk1. This cell line is characterized by 
a very stable karyotype and high gene targeting frequencies, 
  allowing the establishment of double and even triple mutants 
(Sonoda et al., 2001). The transformed character of the cell line 
and the use of Xenopus Cdk1 might be a potential drawback of 
Figure 6.  Causal relationship of Geminin destruction and 
origin licensing in mitotic HeLa cells after Cdk1 inhibition. 
(A) Chromatin fractionation of Nocodazole (Noc) arrested cells 
with the indicated additions. MG132 was added to mitotic 
cells after a 12-h incubation in Nocodazole. 50 μM Roscovi-
tine was added 1 h later, and the cells were incubated for an 
additional 2 h. Shown are the immunoblots of soluble and 
chromatin fractions with the indicated antisera. (B) Degrada-
tion of APC/C substrates Cdc20 and Aurora kinase A after 
Roscovitine treatment of Nocodazole arrested HeLa cells. Cell 
lysates before or 2 h after 50 μM Roscovitine treatment 
were analyzed by immunoblotting with the indicated antibodies. 
(C) Chromatin fractionation of Nocodazole-arrested HeLa cells 
after transient expression of the indicated cDNAs. The cells were 
pre-synchronized by a double thymidine block, and transient 
transfections of either GFP or the destruction box deﬁ  cient 
  mutants of cyclin B or Geminin were performed, after release 
from the second thymidine block. Nocodazole was added 7 h 
after the release, and samples were taken after 12 h further 
incubation. The soluble and chromatin fractions were probed 
by immunoblotting with the indicated antisera. Note the absence 
of Cdt1 and Mcm3 in the Roscovitine treated samples contain-
ing the indestructible Geminin mutant (lane 12).CHEMICAL GENETIC ANALYSIS OF CDK1 IN DT40 CELLS • HOCHEGGER ET AL. 265
this approach. However, Cdk functions in cell cycle control are 
highly conserved among different species and cell lines, and the 
S phase functions of Cdk1 described here are likely to be of 
general relevance.
Redundant and speciﬁ  c functions 
of Cdk/cyclin complexes in the cell cycle
Our phenotypic comparison of cdk1as and cdk1as/cdk2
−/− cells 
reveals redundant as well as specifi  c roles of vertebrate Cdk1 in 
the control of DNA replication, centrosome duplication, and 
mitosis (Fig. 7 A). We show that the deletion of Cdk2 renders 
both the initiation of DNA replication and centrosome duplica-
tion dependent on Cdk1 (Fig. 2 and Fig. 3). This suggests that 
Cdk1 and Cdk2 share an essential function in the control of 
S phase. Our fi  ndings also suggest that the centrosome cycle 
and the cell cycle can be uncoupled simply by blocking entry 
into mitosis, and that either Cdk1 or 2 activity is required to 
drive this cell cycle–independent centrosome amplifi  cation.
In principle, the experiment in Fig. 3 C shows that mid 
S phase cells do not need Cdk1/2 activity to continue replication. 
However, the dynamics of S phase completion appear to be 
changed after Cdk1 inhibition in cdk1as/cdk2
−/− cells. A detailed 
analysis of late origin fi  ring and the dynamics of replication 
elongation will be necessary to determine the roles of Cdk1/2 
during ongoing replication.
The functional overlap of Cdk1 and Cdk2 does not in-
clude the mitotic functions of Cdk1, which cannot be com-
pensated by Cdk2. We also found that neither Cdk1 nor Cdk2 
appear to control the events of early G1 phase such as initiation 
of de novo cyclin synthesis (Fig. 3 D), which is likely to be trig-
gered by Cdk4/6. Moreover, we cannot exclude at this point that 
either kinase carries out other specifi  c functions that evade our 
phenotypic analysis.
It remains to be addressed, which of the different cyclins 
is primarily responsible for the S phase functions of Cdk1. 
A-type and B-type cyclins, the predominant binding partners of 
Cdk1as in the DT40 cells (Fig. S3 E) can both initiate DNA 
replication (Strausfeld et al., 1996; Moore et al., 2003). Cyclin A 
is the more likely candidate for this function, because cyclin 
B/Cdk1 is rapidly exported from the nucleus during S phase 
(Yang et al., 1998) and kept inactive by the Wee1 kinase (Chow 
et al., 2003). However, a recent study suggests that cyclin E is 
also capable of binding and activating Cdk1, especially after 
deletion of Cdk2 (Aleem et al., 2005). The precise functions of 
the individual cyclins during S phase need to be addressed in 
future studies.
Figure 7.  Mechanisms of endoreplication control during G2 phase. (A) HeLa cells were transfected with scrambled siRNA (lanes 1–3) or Geminin siRNA 
(lanes 4–6) and synchronized by a double thymidine block. 8 h after release we added 50 μM Roscovitine (lane 1 and 4), 10 μM MG132 (lane 2 and 5), 
or both (lane 3 and 6). After a further 2 h of incubation we prepared soluble (left) and chromatin-enriched (right) fractions and analyzed for the presence 
of the indicated proteins by immunoblotting. (B) Diagram of the synchronization protocol used to induce endoreplication in G2 cells. (C) Left panel: DNA 
content analysis of the same cells as described in A. Right panel: a part of these cells were washed in excess medium and cultured for a further 12 h, before 
DNA content analysis. The percentage of cells with DNA content greater then 4N is shown. (D) Cells were synchronized by a double thymidine block 
(lane 1 and 5), released for 8 h (lane 2 and 6), further incubated for 4 h in 50 μM roscovitine (lane 3 and 7), or Nocodazole (lane 4 and 8). Extracts of 
these cells were analyzed by immunoblotting with two different Cdt1 antibodies and antibodies raised against Mcm3 and 4.JCB • VOLUME 178 • NUMBER 2 • 2007  266
Differential control of endoreplication 
during G2 and M phase
Our study points to fundamentally different mechanisms in 
the control of endoreplication before and after mitotic Cdk1 
activation and entry into M phase. The three main players of 
licensing control in vertebrate appear to be Geminin and Cdk1 
(and possibly Cdk2), as well as proteolysis pathways such as 
the degradation of Geminin and Cdt1. In the following section 
we will discuss our fi  ndings on the function of these players 
comparing G2 to M phase. A summary of this discussion is 
presented in Fig. 8 B.
Geminin inhibits origin licensing 
independently of Cdks
Our results in Fig. 6 and Fig. 7 show that removal of Geminin is 
a necessity for origin licensing both in G2 and M phase, and that 
Geminin can act independently of Cdk activity. This idea is not 
supported by a previous study (Ballabeni et al., 2004), where 
Roscovitine treatment does not cause APC/C activation and 
Geminin degradation in mitotic HeLa cells. In contrast, we ob-
served in consistence with previous studies (Listovsky et al., 
2000) that the APC/C was rapidly activated upon mitotic Cdk1 
inactivation causing the degradation of Geminin as well as other 
APC/C substrates (Fig. 6 A). We also confi  rmed that a degrada-
tion resistant Geminin mutant inhibited origin licensing, even 
after Cdk1 inactivation (Fig. 6 C). The discrepancy between our 
and Ballabeni et al.’s (2004) results may be due to the twofold 
lower doses of Roscovitine used in the previous study, which 
may trigger Geminin degradation only partially.
Effects of Cdk1 inhibition on 
endoreplication in G2 and M phase
We found that specifi  c inhibition of both Cdk1 and Cdk2 initi-
ated neither origin licensing nor DNA re-replication during 
G2 phase in DT40 (Fig. 4 B). The same result was obtained from 
Roscovitine-treated HeLa cells (Fig. 4 D). Paradoxically, Cdk1 
inhibition in prometaphase rapidly triggered origin licensing 
and endoreplication (Fig. 5, B and G, lane 2 and lane 5; and 
Fig. 6 A). Accordingly, Cdk1 inhibition during G2 phase does not 
lead to APC/C activation and Geminin destruction, whereas in 
M phase Cdk1 inactivation results in the rapid removal of Gem-
inin and other APC/C substrates (Fig. 6, A and B). The presence 
of the APC/C inhibitor Emi1 during G2 but not during M phase 
(Reimann et al., 2001; Margottin-Goguet et al., 2003) is a likely 
explanation for this difference in APC/C activity between the 
two different cell cycle phases. This idea is supported by a re-
cent report by Machida and Dutta (2007), which demonstrates 
that depletion of the APC/C inhibitor Emi1 is suffi  cient to in-
duce endoreplication in human cells.
In contrast to our results, the APC/C appears to be activated 
during G2 phase in Cdk1 depleted HT2-19 human cells and 
Drosophila cells (Hayashi, 1996; Laronne et al., 2003). This could 
explain the observed endoreplication in these cells after Cdk1 
inactivation. The premature APC/C activation in G2 might be an 
effect of incomplete Cdk1 inactivation, which could allow Emi1 
degradation, while not being suffi  cient to trigger mitosis. Alter-
natively, Emi1 levels might differ among different cell lines.
Licensing control by proteolysis during 
the G2 phase
When we analyzed the redundant roles of Geminin and Cdks in 
the control of origin licensing in the G2 phase, we made the sur-
prising observation that Cdk inhibition did not trigger Mcm load-
ing onto chromatin, even after Geminin depletion. This suggests 
the presence of an additional control mechanism that suppresses 
endoreplication in the G2 phase. Accordingly, we found that the 
licensing factor Cdt1 did not accumulate during G2 phase even 
after Cdk1 inhibition (Fig. 7 A, lane 1; and Fig. 7 D). Conversely, 
Cdt1 appears to accumulate once cells enter M phase (Fig. 7 D).
Accordingly, we found that transient inhibition of proteo-
lysis stabilized Cdt1, and was suffi  cient to induce a new round 
of DNA replication in Geminin-depleted cells. This MG132 in-
duced endo-replication occurred regardless of the state of Cdk 
activity, suggesting that Geminin and proteolysis are the major 
control mechanisms that block endoreplication in G2 phase. 
The question remains what the essential targets of these prote-
olysis pathways are. Degradation of the licensing factor Cdt1 is 
an obvious candidate (Zhong et al., 2003), but other players 
such as orc1 (Mendez et al., 2002), and the degradation of 
Cdk inhibitors such as p21 and p27 might also be involved 
(Nakayama et al., 2004). Defi  ning these essential proteolysis 
targets for licensing control in G2 phase will be an important 
challenge for future studies.
Collectively, a model emerges in which differential proteoly-
sis of licensing factors and licensing inhibitors control origin licens-
ing during G2 and M phase (Fig. 8 B). In G2 phase the licensing 
inhibitor Geminin is stable, while the licensing factor Cdt1 is 
degraded. Once cells enter mitosis Cdt1 is stabilized and Geminin 
de  gradation by the APC/C is initiated upon induction of anaphase. 
In this way multiple mechanisms ensure in human cells that chromo-
somes are not replicated before the sister chromatids are separated.
Materials and methods
Construction of targeting constructs and vectors
A schematic overview of the CDC2 targeting construct is shown in Fig. S1 A. 
The upstream arm was ampliﬁ  ed using 5′-A  A  C  G  C  G  T  A  A  C  T  A  G  G  A  C  G  G  C  T  C  C-
C  G  A  G  C  A  G  G  -3′ and 5′-G  A  A  A  C  G  C  A  C  A  T  A  G  C  A  A  A  T  A  C  C  A  G  T  C  T  C  A  G  G  -3′ 
Figure 8.  Model of Cdk1 function in controlling DNA replication in verte-
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and cloned into pBS via SacI and BamHI. The downstream arm was ampliﬁ  ed 
using the primers 5′-T  C  C  T  A  A  A  C  T  G  C  T  T  G  T  G  A  A  G  A  A  A  T  A  A  G  C  A  G  G  -3′ and 
5′-C  C  T  G  C  T  T  A  T  T  T  C  T  T  C  A  C  A  A  G  C  A  G  T  T  T  A  G  G  A  -3′ cloned into pBS via EcoRI 
and SalI. BSR or Neomycin selection markers were cloned into the BamHI site 
of the construct. Gene targeting of DT40 cells was performed as described 
previously (Sonoda et al., 1998). The Neomycin resistance cassette was 
ﬂ  anked by two loxP sequences, and was removed from the chicken genome 
by transient expression of the Cre-recombinase. Neomycin sensitive cells were 
isolated by subcloning. Xenopus leavis Cdk1myc was cloned into pIRES2-
EGFP (CLONTECH Laboratories, Inc.) via BamHI–EcoRI. Mutagenesis was 
performed using a standard PCR protocol. Stable integration of this vector in 
the DT40 genome was achieved by electroporating 20 μg of the linearized 
Cdk1 expression vector into DT40 cells, and selection of Neomycin resistant 
colonies as described previously (Sonoda et al., 1998).
The chicken cDNA for Cdk2 was cloned by RT-PCR using the primers 
5′-A  T  G  G  A  G  A  A  C  T  T  T  C  A  A  A  A  G  G  T  G  G  A  G  A  -3′ and 5′-G  G  C  T  G  T  C  C  C  C  C  A-
C  C  T  G  C  G  C  C  T  G  T  G  A  -3′, and the sequence was submitted to the NCBI 
GenBank (accession number EF182713). A schematic overview of the 
CDK2 gene disruption construct is shown in Fig. S3 A. There is no genomic 
information available for the chicken CDK2 gene, and we were not able to 
amplify its genomic sequences by PCR. We screened a chicken genomic 
DNA pool (provided by RZPD Deutsches Ressourcenzentrum für Genom-
forschung GmbH) for a CDK2 gene containing fragment using PCR with 
chicken CDK2 cDNA primers 5′-G  T  C  G  T  G  T  A  C  A  A  G  G  C  C  C  G  G  A  A  C  A  A  G  G-
T  C  A  C  G  -3′ and 5′-C  G  C  T  G  C  C  T  T  G  G  C  C  G  A  G  A  T  G  C  G  C  T  T  G  T  T  G  G  G  -3′, and 
analyzed isolated clones by Southern blot analysis with a chicken Cdk2 
cDNA probe. We generated the targeting constructs by restriction enzyme 
digestion of the isolated cosmid clone. A BglII fragment was isolated up-
stream of exon 2 for the 5′ arm, and an EcoRV NotI fragment between 
exon 5 and 6 was isolated for the 3′ arm. The fragments were cloned into 
pCR 2.1-TOPO vector (Invitrogen). Selection cassettes (either His or Puro 
ﬂ  anked with two LoxP sequences) were inserted into the construct at EcoRI–
EcoRV sites by blunt-end ligation.
The following primers were used to detect Cdk1 and 2 ortho-
logues by RT-PCR: Xenopus laevis Cdk1 (5′-A  T  G  A  A  G  A  A  A  A  T  T  C  G  A  T  T-
G  G  A  A  A  A  C  G  -3′ and 5′-G  A  T  C  T  C  C  G  A  G  G  A  G  G  A  C  C  T  G  A  A  C  TAA-3′), 
Gallus Cdk1 (5′-AT  G  G  A  G  G  A  T  T  A  C  A  C  G  A  A  G  A  T  A  G  A  G  A  A  G  A  T  T  -3′ and 
5′-C  T  T  C  C  T  G  C  T  A  A  T  C  T  G  A  T  T  A  A  G  A  A  A  T  T  C  T  A  A  -3′), and Gallus Cdk2 
(5′-T  A  C  C  T  G  T  T  C  C  A  G  C  T  G  C  T  G  C  A  A  G  G  C  C  -3′ and 5′-G  G  C  T  C  A  A  A  T    G  C  T  G-
C  A  C  T  A  C    G  A  T  C  C  C  -3′).
Human Geminin was cloned by RT-PCR and the destruction box 
(amino acid residues 23–30) was deleted as described by Benjamin et al., 
(2004). Mouse cyclin B1 destruction box mutant (R42A; L45A) in pEVT7 
was a gift from Stephan Geley (Medical University Innsbruck, Austria).
Cell culture, transfection, and synchronization
DT40 cells were cultured, and transfected as described previously (Sonoda 
et al., 1998). Takata et al. (1998) described the synchronization of DT40 
cell by elutriation. 1NM-PP1 was obtained from Cellular Genomics and 
used at the indicated concentrations (1–10 μM). We used a 50-μM con-
centration of Roscovitine (Calbiochem), and a 5-μM concentration of 
MG-132 (Calbiochem). Cell cycle analysis of BrdU-pulsed and PI-stained 
samples was performed on a FACScan (Becton Dickinson) using Cell-
Quest software (Takata et al., (1998). HeLa cells were synchronized in 
mitosis by incubation in 100 ng/ml Nocodazole, and in S phase by a 
double thymidine block. In brief, cells were incubated for 14 h in 2 mM 
thymidine, washed in PBS, released for 10 h, and then blocked for 
  another 14 h in 2 mM thymidine. Transient transfection of HeLa cells by 
  Lipofectamine (Invitrogen) was performed following the second thymidine 
block as described in the manufacturer’s protocol. To target Geminin we 
transfected a QIAGEN-validated siRNA SI02653805 at a ﬁ  nal concen-
tration of 100 nM by oligofectamine (Invitrogen), following the manufac-
turer’s instructions.
Preparation of total cell extracts and chromatin fractionation
For total cell extraction, 10
6 DT40 cells or 10
5 HeLa cells were lysed in 10 μl 
ECB buffer (50 mM Tris, pH 7.5, 120 mM NaCl, 0.5% NP-40, and 1 mM 
EDTA) containing 1 mM DTT and a 1:100 dilution of a protease inhibitor 
cocktail (Nakalai Tesque 25955-11). The extracts were incubated for 
20 min on ice, sonicated, and suspended in 2× Laemmli buffer. For chromatin 
fractionation, we separated soluble and insoluble fractions as described 
by Ballabeni et al. (2004). 10
6 DT40 or 10
5 HeLa cells were ﬁ  rst lysed for 
20 min in 10 μl CSK buffer containing DTT and protease inhibitors as 
above. Following centrifugation, the supernatant was mixed with 2× Laemmili 
buffer, and the pellet was washed and resuspended in 10 μl CSK buffer, 
sonicated and suspended in 2× Laemmli buffer.
Immunoblotting, Immunoprecipitation, immunoﬂ  uorescence, 
and Histone H1 kinase assays
Immunoblotting and immunoprecipitation, and histone H1 kinase assays 
were done as described earlier (Sonoda et al., 1998; Chow et al., 2003). 
Immunoﬂ  uorescence of cyclin B was performed with formaldehyde ﬁ  xed 
samples that were spun on a glass slide by centrifugation in a Cytospin 
centrifuge.  α- and γ-tubulin immunoﬂ   uorescence was performed as de-
scribed earlier (Yamaguchi-Iwai et al., 1999).
Image acquisition and manipulation
All images were taken with an Olympus BX61 microscope, equipped with 
a Photometrics CoolSnap HQ camera, and Olympus Uplan/APO 100× 
lens (NA 1.35). Samples were mounted in Vectashield mounting medium 
with DAPI (Vector Laboratories, Inc.) and analyzed at room temperature. 
Image acquisition was performed using MetaMorph software.
Antibodies
Antibodies used in this study comprised the anti Cdk1 mouse monoclonal 
A17 antibody (Gannon et al., 1998), rabbit polyclonal anti Cdk1 anti-
body from Upstate Biotechnologies, rabbit polyclonal anti Cdk2 antibody 
from Abcam (ab-7954-1), anti-PSTAIRE (Poon et al., 1997), and rabbit 
polyclonal anti-phosphotyrosine15 Cdk1 antibody from Cell Signaling 
(Nr. 9111S). (06-923). Anti-chicken cyclin A (Maridor et al., 1993) and 
anti-chicken cyclin B2 (Gallant and Nigg, 1992) antibodies were gifts from 
E. Nigg’s laboratory (MPI of Biochemistry, Munich, Germany); monoclonal 
anti-α-tubulin FITC conjugate (No. F2168), and γ-tubulin polyclonal (No. 
T3559) antibodies were obtained from Sigma-Aldrich; Mcm2, 3, 4, and 
Histone H2A polyclonal antibodies were obtained from Abcam (ab 4461-
50, 4460-50, 3728-50, 13923-100, respectively); and anti–human Cdt1 
antibody was a gift from H. Nishitani (Kyushu University, Fukuoka, Japan; 
Nishitani et al., 2001). The Cdt1 antibody used in Fig. 7 was purchased 
from Santa Cruz Biotechnology, Inc. (sc-28262). Aurora kinase A rabbit 
polyclonal antibodies were purchased from Abcam (ab12875), and to 
detect Cdc20 we used a mixture of two monoclonal anti-cdc20 antibodies 
from Santa Cruz Biotechnology, Inc. (SC1907 and SC1906). Human cyclin 
B1 monoclonal V152 antibodies (ab-72) and rabbit polyclonal anti-Geminin 
antibodies (ab-12147-50) were obtained from Abcam. For FACS analysis, 
ethanol-ﬁ  xed cells were stained with anti-BrdU monoclonal antibody (BD 
Biosciences; Nr. 555627) and anti-phospho Ser10 rabbit polyclonal 
Histone H3 antibody (Upstate Biotechnology; Nr. 06-570). Alexa-labeled 
secondary antibodies were purchased from Molecular Probes, and HRP-
  labeled secondary antibodies were from Santa Cruz Biotechnology. Cdc27 
was detected by a monoclonal antibody from Abcam (ab10538).
Online supplemental material
Fig. S1 shows generation of cdk1as cells. Fig. S2 shows synchronous mito-
sis after release from G2 arrest. Fig. S3 shows gene targeting of CDK2 in 
cdk1as cells. Fig. S4 shows G1 arrest in cdk1as/cdk2
−/− cells.
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